Rosenberg ES - Search Results

1

Genetic and immunologic heterogeneity among persons who control HIV infection in the absence of therapy.

Pereyra F, Addo MM, Kaufmann DE, Liu Y, Miura T, Rathod A, Baker B, Trocha A, Rosenberg R, Mackey E, Ueda P, Lu Z, Cohen D, Wrin T, Petropoulos CJ, Rosenberg ES, Walker BD. Pereyra F, et al. Among authors: rosenberg es, rosenberg r. J Infect Dis. 2008 Feb 15;197(4):563-71. doi: 10.1086/526786. J Infect Dis. 2008. PMID: 18275276

2

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia.

Rosenberg ES, Billingsley JM, Caliendo AM, Boswell SL, Sax PE, Kalams SA, Walker BD. Rosenberg ES, et al. Science. 1997 Nov 21;278(5342):1447-50. doi: 10.1126/science.278.5342.1447. Science. 1997. PMID: 9367954

3

HIV type 1-specific helper T cells: a critical host defense.

Rosenberg ES, Walker BD. Rosenberg ES, et al. AIDS Res Hum Retroviruses. 1998 Jun;14 Suppl 2:S143-7. AIDS Res Hum Retroviruses. 1998. PMID: 9672231 Review. No abstract available.

4

Immune control of HIV-1 replication.

Walker BD, Rosenberg ES, Hay CM, Basgoz N, Yang OO. Walker BD, et al. Among authors: rosenberg es. Adv Exp Med Biol. 1998;452:159-67. doi: 10.1007/978-1-4615-5355-7_17. Adv Exp Med Biol. 1998. PMID: 9889969 Review. No abstract available.

5

Acute HIV infection among patients tested for mononucleosis.

Rosenberg ES, Caliendo AM, Walker BD. Rosenberg ES, et al. N Engl J Med. 1999 Mar 25;340(12):969. doi: 10.1056/nejm199903253401217. N Engl J Med. 1999. PMID: 10094651 No abstract available.

6

Characterization of HIV-1-specific T-helper cells in acute and chronic infection.

Rosenberg ES, LaRosa L, Flynn T, Robbins G, Walker BD. Rosenberg ES, et al. Immunol Lett. 1999 Mar;66(1-3):89-93. doi: 10.1016/s0165-2478(98)00165-5. Immunol Lett. 1999. PMID: 10203039

7

Control of HIV despite the discontinuation of antiretroviral therapy.

Lisziewicz J, Rosenberg E, Lieberman J, Jessen H, Lopalco L, Siliciano R, Walker B, Lori F. Lisziewicz J, et al. N Engl J Med. 1999 May 27;340(21):1683-4. doi: 10.1056/NEJM199905273402114. N Engl J Med. 1999. PMID: 10348681 No abstract available.

8

Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection.

Kalams SA, Buchbinder SP, Rosenberg ES, Billingsley JM, Colbert DS, Jones NG, Shea AK, Trocha AK, Walker BD. Kalams SA, et al. Among authors: rosenberg es. J Virol. 1999 Aug;73(8):6715-20. doi: 10.1128/JVI.73.8.6715-6720.1999. J Virol. 1999. PMID: 10400769 Free PMC article.

9

Reduced antiretroviral drug susceptibility among patients with primary HIV infection.

Little SJ, Daar ES, D'Aquila RT, Keiser PH, Connick E, Whitcomb JM, Hellmann NS, Petropoulos CJ, Sutton L, Pitt JA, Rosenberg ES, Koup RA, Walker BD, Richman DD. Little SJ, et al. Among authors: rosenberg es. JAMA. 1999 Sep 22-29;282(12):1142-9. doi: 10.1001/jama.282.12.1142. JAMA. 1999. PMID: 10501117

10

Treatment of human immunodeficiency virus infection with hydroxyurea, didanosine, and a protease inhibitor before seroconversion is associated with normalized immune parameters and limited viral reservoir.

Lori F, Jessen H, Lieberman J, Finzi D, Rosenberg E, Tinelli C, Walker B, Siliciano RF, Lisziewicz J. Lori F, et al. J Infect Dis. 1999 Dec;180(6):1827-32. doi: 10.1086/315113. J Infect Dis. 1999. PMID: 10558937 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

429 results

Search Page

Filters